ATA327387A - Pharmazeutisches ranitidinpraeparat - Google Patents

Pharmazeutisches ranitidinpraeparat

Info

Publication number
ATA327387A
ATA327387A AT0327387A AT327387A ATA327387A AT A327387 A ATA327387 A AT A327387A AT 0327387 A AT0327387 A AT 0327387A AT 327387 A AT327387 A AT 327387A AT A327387 A ATA327387 A AT A327387A
Authority
AT
Austria
Prior art keywords
pharmaceutical
ranitidine
preparation
ranitidine preparation
pharmaceutical ranitidine
Prior art date
Application number
AT0327387A
Other languages
English (en)
Other versions
AT395373B (de
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10608930&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATA327387(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of ATA327387A publication Critical patent/ATA327387A/de
Application granted granted Critical
Publication of AT395373B publication Critical patent/AT395373B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Furan Compounds (AREA)
AT0327387A 1986-12-12 1987-12-11 Pharmazeutisches ranitidinpraeparat AT395373B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868629781A GB8629781D0 (en) 1986-12-12 1986-12-12 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
ATA327387A true ATA327387A (de) 1992-05-15
AT395373B AT395373B (de) 1992-12-10

Family

ID=10608930

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0327387A AT395373B (de) 1986-12-12 1987-12-11 Pharmazeutisches ranitidinpraeparat

Country Status (23)

Country Link
US (1) US5068249A (de)
JP (1) JP2590156B2 (de)
KR (1) KR960008228B1 (de)
AT (1) AT395373B (de)
AU (1) AU607451B2 (de)
BE (1) BE1000624A5 (de)
CA (1) CA1303993C (de)
CH (1) CH675207A5 (de)
CZ (1) CZ281599B6 (de)
DE (1) DE3742127C2 (de)
DK (1) DK167842B1 (de)
FR (1) FR2608921B1 (de)
GB (2) GB8629781D0 (de)
HK (1) HK19095A (de)
IE (1) IE60618B1 (de)
IL (1) IL84795A0 (de)
IT (1) IT1211967B (de)
NL (1) NL194431C (de)
NZ (1) NZ222879A (de)
PH (1) PH25390A (de)
SE (1) SE504333C2 (de)
YU (1) YU46561B (de)
ZA (1) ZA879338B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8925484D0 (en) * 1989-11-10 1989-12-28 Glaxo Group Ltd Process
GB9019875D0 (en) * 1990-09-11 1990-10-24 Glaxo Group Ltd Pharmaceutical compositions
US5169864A (en) * 1991-11-15 1992-12-08 Baxter International Inc. Unbuffered premixed ranitidine formulation
WO1995010274A1 (en) * 1993-10-14 1995-04-20 F.H. Faulding & Co. Limited Aqueous pharmaceutical composition
US5407687A (en) * 1994-02-22 1995-04-18 Glaxo Inc. Ranitidine solid dosage form
WO1996001129A1 (en) * 1994-07-06 1996-01-18 Farmarc Nederland B.V. Inclusion complexes of ranitidine
HU213598B (en) * 1994-10-18 1997-08-28 Ge Lighting Tungsram Rt One-side socketed discharge lamp
US5538737A (en) * 1994-11-30 1996-07-23 Applied Analytical Industries, Inc. Oral compositions of H2 -antagonists
US5976578A (en) * 1996-10-10 1999-11-02 Mcneil-Ppc, Inc. Liquid antacid compositions
GB9715423D0 (en) 1997-07-23 1997-09-24 Glaxo Group Ltd Aqueous compositions
KR100412290B1 (ko) * 2001-11-27 2003-12-31 주식회사 동구제약 라니티딘 함유 현탁제 조성물 및 그의 제조방법
US20060100271A1 (en) * 2004-11-08 2006-05-11 Keith Whitehead Stabilized aqueous ranitidine compositions
ES2382993T3 (es) 2006-07-21 2012-06-15 Lyne Laboratories, Inc. Composición líquida de acetato de calcio
GR1009069B (el) * 2015-01-05 2017-07-07 Λαμδα Φαρμακευτικα Εργαστηρια Εφαρμοσμενης Ερευνας & Αναπτυξης Α.Ε. Ποσιμα διαλυματα υψηλης συγκεντρωσης που περιεχουν υδροχλωρικη ρανιτιδινη

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2735587A1 (de) * 1977-08-06 1979-02-15 Sandoz Ag Stabile loesungen und verfahren zu deren herstellung
GB1565966A (en) * 1976-08-04 1980-04-23 Allen & Hanburys Ltd Aminoalkyl furan derivatives
IL63968A (en) * 1980-10-01 1985-10-31 Glaxo Group Ltd Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it
DE3108753A1 (de) * 1981-03-07 1982-09-16 Degussa Ag, 6000 Frankfurt Neue substituierte alkyl-phenylsulfonylguanidine miteinem heterocyclischen rest
CA1211374A (en) * 1982-05-14 1986-09-16 Eszter Cholnoky Pharmaceutical compositions containing more active ingredients
JPS59101478A (ja) * 1982-11-29 1984-06-12 Sunstar Inc リグスチライドを安定に配合した水系組成物
GB8313217D0 (en) * 1983-05-13 1983-06-22 Glaxo Group Ltd Pharmaceutical compositions
SE8704436D0 (sv) * 1987-11-13 1987-11-13 Pm Konsult Handelsbolag Anvendning av antisekretoriska substanser for nya indikationer

Also Published As

Publication number Publication date
DK652787A (da) 1988-06-13
AU607451B2 (en) 1991-03-07
FR2608921A1 (fr) 1988-07-01
YU224587A (en) 1990-10-31
DE3742127A1 (de) 1988-10-06
DK652787D0 (da) 1987-12-11
IE60618B1 (en) 1994-07-27
FR2608921B1 (fr) 1991-04-12
AU8244487A (en) 1988-06-16
IT1211967B (it) 1989-11-08
GB8728957D0 (en) 1988-01-27
GB8629781D0 (en) 1987-01-21
CA1303993C (en) 1992-06-23
HK19095A (en) 1995-02-17
ZA879338B (en) 1989-02-22
GB2198352A (en) 1988-06-15
CZ281599B6 (cs) 1996-11-13
NL194431B (nl) 2001-12-03
PH25390A (en) 1991-06-03
SE8704952D0 (sv) 1987-12-11
KR960008228B1 (ko) 1996-06-21
IT8748698A0 (it) 1987-12-11
IE873367L (en) 1988-06-12
AT395373B (de) 1992-12-10
SE504333C2 (sv) 1997-01-13
KR880007060A (ko) 1988-08-26
NL8703000A (nl) 1988-07-01
IL84795A0 (en) 1988-05-31
JPS63215622A (ja) 1988-09-08
CS403791A3 (en) 1992-08-12
YU46561B (sh) 1993-11-16
BE1000624A5 (fr) 1989-02-21
DE3742127C2 (de) 1997-08-28
JP2590156B2 (ja) 1997-03-12
US5068249A (en) 1991-11-26
NL194431C (nl) 2002-04-04
SE8704952L (sv) 1988-06-13
DK167842B1 (da) 1993-12-27
NZ222879A (en) 1990-08-28
CH675207A5 (de) 1990-09-14
GB2198352B (en) 1990-11-28

Similar Documents

Publication Publication Date Title
DK195988A (da) Farmaceutisk praeparat indeholdende mikrokapsler
DK89090D0 (da) Farmaceutisk praeparat
DK406788D0 (da) Smags-sloerende farmaceutisk forbindelse
KR880011653U (ko) 의약용 캅셀
DK546886D0 (da) Farmaceutisk praeparat
NO873534L (no) Stabilt farmasoeytisk gelpreparat.
DK489189D0 (da) Farmaceutisk praeparat
DK705488A (da) Farmaceutisk praeparat
NL194749B (nl) Stabiel calciumhoudend farmaceutisch preparaat.
DK413987D0 (da) Farmaceutiske praeparater
ATA327387A (de) Pharmazeutisches ranitidinpraeparat
DK603988D0 (da) Farmaceutisk praeparat
MX172943B (es) Formulacion farmaceutica
DK336489A (da) Farmaceutisk praeparat
DK139388D0 (da) Farmaceutisk praeparat
DK447887A (da) Frysetoerrede farmaceutiske praeparater
DK276288A (da) Farmaceutisk praeparat
DK624587D0 (da) Farmaceutisk praeparat indeholdende imidazolderivater
IT1216814B (it) Composizioni farmaceutiche
DK138888D0 (da) Farmaceutisk praeparat
DK428287D0 (da) Nasalt farmaceutisk praeparat
SE8603912D0 (sv) Farmaceutisk beredning
SE8602975D0 (sv) Farmaceutisk beredning
DK149588A (da) Xylometazolinholdige farmaceutiske praeparater
DK638889A (da) Farmaceutisk kombinationspraeparat

Legal Events

Date Code Title Description
ELA Expired due to lapse of time